Research by Kawaguchi et al. found that the high expression of FABP5 in metastatic CRC cells stems from promoter demethylation, and this hypomethylated state is closely linked to the expression pattern of DNMT3B splice variants [57]. Here, FABP5 is linked to colorectal carcinoma.